Literature DB >> 6797948

Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.

I A Holder, R Wheeler, T C Montie.   

Abstract

Recent reports have suggested that motility is associated with virulence in Pseudomonas aeruginosa. We have confirmed this observation by showing that groups of mice immunized with P. aeruginosa flagellar-antigen preparations display enhanced survival when they are subsequently burned and challenged locally in the burned area with strains of P. aeruginosa. The protection appears to be due to the immobilization of the microorganisms in the burned skin tissue. Liver elongation factor 2 is also protected. The protection afforded by immunization with flagellar-antigen preparations is independent of the somatic antigenic type of the challenging strain but is flagellar-antigen specific. These data suggest that vaccination with flagellar-antigen preparations may provide a viable prophylactic or therapeutic alternative to antibiotic therapy for use in compromised patient population in which P. aeruginosa poses a serious infection threat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6797948      PMCID: PMC351026          DOI: 10.1128/iai.35.1.276-280.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  The elongation factor 2 content of mammalian cells. Assay method and relation to ribosome number.

Authors:  D M Gill; L L Dinius
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

2.  Motility and chemotaxis of three strains of Pseudomonas aeruginosa used for virulence studies.

Authors:  R C Craven; T C Montie
Journal:  Can J Microbiol       Date:  1981-04       Impact factor: 2.419

3.  Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues.

Authors:  D G Saymen; P Nathan; I A Holder; E O Hill; B G Macmillan
Journal:  Appl Microbiol       Date:  1972-03

4.  Serological properties of Pseudomonas aeruginosa. II. Type-specific thermolabile (flagellar) antigens.

Authors:  B Lányi
Journal:  Acta Microbiol Acad Sci Hung       Date:  1970

5.  Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.

Authors:  O R Pavlovskis; B Wretlind
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

7.  Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.

Authors:  C B Saelinger; K Snell; I A Holder
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

8.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.

Authors:  I A Holder; C G Haidaris
Journal:  Can J Microbiol       Date:  1979-05       Impact factor: 2.419

9.  Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.

Authors:  K Snell; I A Holder; S A Leppla; C B Saelinger
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  37 in total

1.  Pseudomonas aeruginosa immunotherapy.

Authors:  J E Pennington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

2.  Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; T McVeigh; P Owen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

3.  Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum.

Authors:  T R Anderson; T C Montie
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 4.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

5.  Interleukin-8 production by human airway epithelial cells in response to Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins.

Authors:  Kathleen K Shanks; Wei Guang; K Chul Kim; Erik P Lillehoj
Journal:  Clin Vaccine Immunol       Date:  2010-06-30

6.  Enzyme-linked immunosorbent assay for detection of Pseudomonas aeruginosa H (flagellar) antigen.

Authors:  T C Montie; T R Anderson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

7.  Effect of antiflagellar serum in the protection of mice against Clostridium chauvoei.

Authors:  Y Tamura; S Tanaka
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Phenotypic factors correlated with the absence of virulence among gentamicin-resistant Pseudomonas aeruginosa strains.

Authors:  R B Clark; J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique.

Authors:  R A Ansorg; M E Knoche; A F Spies; C J Kraus
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

10.  Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin.

Authors:  G Molinari; P Paglia; G C Schito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.